Az első onkológiai ellátás időfaktorának szerepe a daganatos betegségek túlélési mutatóiban. Irodalmi áttekintés
Author(s) -
László Mangel,
Tamás Tornóczky,
Antal Zemplényi,
I Boncz
Publication year - 2018
Publication title -
orvosi hetilap
Language(s) - Hungarian
Resource type - Journals
SCImago Journal Rank - 0.176
H-Index - 21
eISSN - 1788-6120
pISSN - 0030-6002
DOI - 10.1556/650.2018.30920
Subject(s) - medicine , psychosocial , oncology , cancer , breast cancer , gynecology , family medicine , psychiatry
The aim of this study was to survey the effects of the waiting time for the first oncology treatment in cancer diseases. By the analysis of 67 retrospective studies and reviews the numerical effects of treatment initiation time on survival were assessed. The "time factor" has a leading role on cancer types with aggressive biological behaviour, like breast cancer in younger age, testicular cancers, or head and neck tumours. However, a few days and reasonable delay to the first oncology intervention has no negative impact in numerous cancer diseases. The course of the primary check-up could be modified by several medical and psychosocial factors, and many times the treatment of the most advanced cancers are privileged causing an inverse survival effect. The effectiveness of the cancer therapies is determined by the optimal treatment decision, however, further research is necessary for the determination of the exact role of the "time factor" in oncology. Orv Hetil. 2018; 159(14): 535-546.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom